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Diabetic muscle infarction (DMI) is an under-
recognized diabetic complication characterized by
muscle pain and swelling. It usually occurs in subjects
with long-standing diabetes and known microvas-
cular complications. There are no useful biochemical
markers for this disease and it can easily be misdiag-
nosed as soft tissue infection. The exact pathogenesis
of DMI is unclear. This case report presents a type 2
diabetic patient who was diagnosed with DMI after
being treated with terlipressin for gastrointestinal
bleeding.
CASE PRESENTATION
This 45-year-old male had been diagnosed with type
2 diabetes with nephropathy, retinopathy and neurop-
athy. He was also known to have hepatitis C-related
liver cirrhosis and had experienced several episodes
of esophageal varices and gastric ulcer bleeding prior
to admission. On this occasion, he was brought to our
hospital due to another episode of hematemesis. The
patient refused gastroenteroscopy and his gastroin-
testinal bleeding was therefore treated with pantopra-
zole and terlipressin. After treatment for 2 days, he
complained of increasing pain in his right posterior
thigh. Physical examinations revealed a tender and
swollen mass over his right posterior thigh. Labora-
tory data showed a white blood cell count of 8990/μL,
C-reactive protein of 26.6 ng/mL, creatine phosphoki-
nase of 359 U/L, and an erythrocyte sedimentation
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Diabetic muscle infarction (DMI) is a rare complication that often exists in long-standing diabetic
patients. Clinically, it presents with pain, swelling and sometimes a palpable mass, and is often
misdiagnosed as soft tissue infection. The athogenesis of DMI is uncertain. We present the case of
a type 2 diabetic patient with liver cirrhosis who was diagnosed with muscle infarction after
being treated with terlipressin for gastrointestinal bleeding. This 45-year-old male complained of
increasing pain in his right posterior thigh after treatment with terlipressin for 2 days. He was
initially diagnosed with soft tissue infection, but he responded poorly to antibiotic treatment.
Magnetic resonance imaging suggested acute muscle infarction. We performed a muscle biopsy
and the pathologist reported that the muscle was necrotic. After 5 days of bed rest, the patient
was able to walk and was discharged uneventfully.
Key Words: diabetic muscle infarction, terlipressin
(Kaohsiung J Med Sci 2009;25:25–8)
Kaohsiung J Med Sci January 2009 • Vol 25 • No 126
Y.H. Chang, F.C. Yen, M.C. Hsieh, et al
rate of 107 mm/hr. A soft tissue infection was initially
suspected, for which he was treated with antibiotics.
Because he responded poorly, we arranged for mag-
netic resonance imaging (MRI) (Figure 1). The radiol-
ogist strongly suspected that the patient could have
acute muscle infarction, but that a muscle abscess
could not be ruled out. To make an accurate diagnosis,
we performed a muscle biopsy, and the pathologist
reported that the muscle was necrotic (Figure 2). No
microorganisms were detected. Based on these find-
ings, the patient was diagnosed with DMI. Antibiotic
treatment was discontinued and complete bed rest was
advised. After 5 days hospitalization, the patient was
able to walk and was discharged.
DISCUSSION
Angervall and Stener reported the first case of DMI in
1965 [1]. Since then, slightly more than 100 cases have
been reported in the English literature. DMI usually
occurs in patients with long-standing diabetes, espe-
cially type 1 diabetes, with known late complications
such as nephropathy, retinopathy, or neuropathy [2].
There is a slight female predominance and the mean
age at presentation is about 43 years [2,3]. The most
commonly involved sites are the quadriceps (62%),
hip adductors (13%), hamstrings (8%), and hip flexor
muscles (2%) [4].
Typical presentations of DMI include acute onset
pain in the affected muscle, local swelling, and some-
times a palpable mass. Local heat and erythematous
appearance are not usually found on examination of
the skin. The diagnosis must be differentiated from
muscle strain, hematoma, myositis, fasciitis, abscess,
deep vein thrombosis, and thrombophlebitis [5]. There
are no useful biochemical markers for this disease,
though increased plasma levels of creatine phos-
phokinase, a raised erythrocyte sedimentation rate,
and raised leukocyte count might alert physicians of
the possibility of DMI [2,3]. However, because these
abnormalities are nonspecific and easily ignored, 
it is easy to initially misdiagnose DMI as soft tissue
infection.
Nearly all patients with DMI have abnormal find-
ings on MRI. Swollen and edematous muscles dem-
onstrate increased signal intensity on T2-weighted,
post-gadolinium sequences [6]. MRI also makes it
possible to exclude other diseases that mimic DMI.
Sonography is an alternative diagnostic tool; classic
findings include a well-marginated, hypoechoic, intra-
muscular lesion with features of internal linear echo-
genic structures coursing through the lesion [7]. DMI
can be confirmed by muscle biopsy. Light microscopy
will show irregular areas of hemorrhaging, muscle
necrosis, and the appearance of granular tissue and
collagen. Replacement of necrotic muscle fibers by
fibrous tissue, myocyte regeneration, and mononuclear
cell infiltration occurs in the late stages [8]. Although
a definite diagnosis can be made by performing a
muscle biopsy, this should be reserved for atypical
cases [3,8].
The main treatment strategy includes bed rest and
pain relief with analgesics. Surgical excision is not
Figure 1. Axial T2-weighted, short tau inversion recovery, 
magnetic resonance imaging shows high signal intensity mainly
in the hamstring muscle of the right thigh. Subfascial fluid accu-
mulation is also seen.
Figure 2. Necrotic skeletal muscle cells without nuclei and 
surrounded by extravasated erythrocytes and inflammatory cells.
recommended because it extends the length of hospi-
tal stay and has been associated with higher recurrence
and mortality compared with nonsurgical treatment
[9]. Symptoms usually resolve in approximately 4–8
weeks, though in nearly 50% of these patients, the
disease may recur [4]. The long-term prognosis is
generally poor, due to the coexistence of lethal macro-
vascular diseases. The mean mortality is 10% within
2 years from the onset of DMI [2].
The pathogenesis of DMI remains unclear. Some
authors have suggested that it results from ischemia
caused by embolization of atheromatous material
[1,10]. However, arteriosclerosis obliterans has also
been thought to be responsible [11]. Some authors have
shown that alterations in the coagulation-fibrinolysis
system and antiphospholipid syndrome might be in-
volved [12,13]. In this case report, the patient devel-
oped DMI after being treated with terlipressin, a potent
vasoconstrictor. Some reports in the literature have as-
sociated the use of terlipressin with serious cardiovas-
cular events and ischemic colitis [14,15]. In this case,
no abnormalities in the patient’s coagulation system
or phospholipid antibodies were detected during treat-
ment, and magnetic resonance angiography of the 
affected leg revealed intact vascularity. Thus, it is prob-
able that the vasoconstrictive effect of terlipressin wors-
ened the blood flow in the affected muscles. Because
the blood supply was impaired, the affected muscle
swelled, leading to mild compartment syndrome,
which further worsened the ischemia and resulted in
muscle necrosis.
In summary, we report the first case of DMI prob-
ably caused by terlipressin. This report suggests that
clinicians should be alert to the possibility of DMI
when using vasoconstrictors in diabetic patients,
especially those who are in the late stages of the dis-
ease and therefore often have compromised blood
circulation.
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Terlipressin 治療後發生糖尿病性肌梗塞 — 
病例報告
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糖尿病性肌梗塞是一個非常少見的糖尿病併發症。通常發生在罹病期長的糖尿病患
者。臨床表徵為一可以觸摸到疼痛、發漲的腫塊，而經常被誤判為軟組織感染。其致
病因仍然不十分清楚。本病例報告一位罹患肝硬化的第 2 型糖尿病患者，因為上消化
道出血而在接受 terlipressin 治療後發生了糖尿病性肌梗塞。他在接受 terlipressin 
治療兩天後開始覺得右後大腿有越來越痛的情形。一開始診斷為軟組織感染並用抗生
素治療，可是效果不佳。經過核磁共振 (magnetic resonance imaging) 檢查後判讀
可能有急性肌肉梗塞。經由肌肉切片確診肌肉壞死。臥床休息 5 天之後，病人開始可
以走動並平安出院。
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